NovellusDx Tissue Collection Protocol

An Observational Study to Assess the Oncogenic Status of Colorectal Cancer Patients That Have Undergone Surgery

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01791322

Enrollment

Registered

2013-02-13

Start date

2014-01-31

Completion date

2016-06-30

Last updated

2018-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients Eligible for Tumor Biopsy, Patients That Have Been Diagnosed With Colorectal Cancer

Brief summary

NovellusDx is developing a diagnostic platform for the personalized cancer therapy based on patient derived tumor tissue. The assay is able to sense activating mutations by monitoring their effect on a chip-based device.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 85 Years

Healthy volunteers

Inclusion criteria

* Patients that have been diagnosed positive for colon cancer. * available treatment follow up during cancer treatment

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame	Description
Correct identification of tumor mutant genes	up to 12 month	Correct identification of tumor mutant genes, in over 85% of the cases

Countries

Israel

Outcome results